一、董事会会议召开情况 利华益维远化学股份有限公司（以下简称"维远股份"或"公司"） 第二届董事会第十五次会议于 2023 年 8 月 25 日以现场结合通讯的方式召 开。本次会议的通知于 2023 年 8 月 15 日以电话、电子邮件等方式向各位 董事发出。本次董事会应参加的董事 7 名，实际参加的董事 7 名。会议由 董事长魏玉东先生召集。本次会议的召集、召开符合《公司法》及《公司 章程》的有关规定，会议决议合法有效。 证券代码：600955 证券简称：维远股份 公告编号：2023-028 利华益维远化学股份有限公司 第二届董事会第十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 二、董事会会议审议情况 （一）审议通过《关于<公司 2023 年半年度报告>及摘要的议案》 表决结果：同意票 7 票、反对票 0 票、弃权票 0 票。 经与会董事表决，审议通过该议案。具体内容详见公司同日在上海证 券交易所网站（www.sse.com.cn）及相关媒体披露的《利华益维远化学股 份有限公司 2023 年半年度 ...

中信证券股份有限公司 关于利华益维远化学股份有限公司 部分调整 2023 年度日常关联交易预计的核查意见 中信证券股份有限公司（以下简称"中信证券"）作为利华益维远化学股份有限公 司（以下简称"维远股份"、"公司"）首次公开发行 A 股股票的保荐机构，根据《证券 发行上市保荐业务管理办法》、《上海证券交易所股票上市规则》、《上海证券交易所上市 公司持续督导工作指引》等法律法规的相关规定，对维远股份部分调整 2023 年度日常 关联交易预计事项进行了审慎核查，核查情况及核查意见如下： 一、公司部分调整 2023 年度日常关联交易预计情况 住所：为利津县永莘路 55 号 法定代表人索树城，注册资本 43,527.32 万元，住所为利津县永莘路 55 号，经营范 围为危险化学品生产；发电、输电、供电业务；热力生产和供应；技术进出口；货物进 出口；进出口代理。石油制品制造（不含危险化学品）；石油制品销售（不含危险化学 品）；化工产品生产（不含许可类化工产品）；化工产品销售（不含许可类化工产品）； 金银制品销售；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；国 内贸易代理；销售代理；金属废料和碎屑加工处理 ...

利华益维远化学股份有限公司 2023年半年度主要经营数据公告 证券代码：600955 证券简称：维远股份 公告编号：2023-031 本公司及董事会全体成员保证本公告内容不存在虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露： 第十三号——化工》的相关要求，利华益维远化学股份有限公司（以下简 称"公司"）现将 2023 年上半年主要经营数据披露如下： 注：新能源新材料相关产品主要包括：碳酸二甲酯、聚碳酸酯、聚碳酸酯改性合金等产品。 二、主要产品及原材料的价格变动情况 （一）主要产品的价格变动情况（不含税） 1 主要产品 产量（万吨） 外销量（万吨） 销售金额（不含税）（万元） 苯酚 24.10 12.77 84,208.90 丙酮 14.88 7.12 36,250.09 双酚 A 12.81 6.14 51,242.39 新能源新材 料相关产品 13.38 9.94 100,841.43 一、主要产品的产量、销量及收入实现情况 单位：元/吨 主要产品 2023 年上半年均价 2022 年上半年均价 同比 ...

证券代码：600955 证券简称：维远股份 公告编号：2023-033 利华益维远化学股份有限公司关于投资 建设AMS分离提纯技术改造项目的公告 本公司及董事会全体成员保证本公告内容不存在虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 项目名称：利华益维远化学股份有限公司（以下简称"公司"）AMS 分离提纯技术改造项目。 ● 投资金额：本项目报批总投资 10,012.31 万元，具体投资金额以实 际投入为准。 ● 特别风险提示:投资项目存在可能面临财务融资、市场竞争、技术、 环保、项目管理和项目建设审批方面的风险影响，导致投资后项目不能实 现预期收益的风险。 一、本次投资项目概述 1、项目投资背景及意义 公司已建设并运行了两套年产 35 万吨的苯酚丙酮装置。苯酚丙酮装置 氧化反应中会有部分副产品 AMS 生成，现有流程是将 AMS 通过加氢重新生 成异丙苯，返回装置继续参与反应生产苯酚和丙酮。 本项目对一、二期 35 万吨/年苯酚丙酮装置进行改造，通过新增 AMS 分离单元把一期、二期 35 万吨/年苯酚丙酮装置所产粗 AMS 物料分离、提 纯为 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥1,692,870,706.42, representing a decrease of 14.37% compared to the same period last year[30]. - The net profit attributable to shareholders for Q1 2023 was ¥26,087,304.88, down 91.41% year-on-year[30]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥17,526,094.22, a decrease of 93.99% compared to the previous year[30]. - The net cash flow from operating activities was ¥36,012,686.90, reflecting a decline of 90.19% year-on-year[30]. - Basic earnings per share for Q1 2023 were ¥0.05, down 90.91% compared to the same period last year[30]. - The total operating revenue for Q1 2023 was CNY 1,692,870,706.42, a decrease of 14.4% compared to CNY 1,976,901,180.72 in Q1 2022[41]. - The net profit for Q1 2023 was CNY 26,087,304.88, down 91.4% from CNY 303,784,338.23 in Q1 2022[42]. - The basic and diluted earnings per share for Q1 2023 were both CNY 0.05, compared to CNY 0.55 in Q1 2022[42]. Assets and Liabilities - Total assets at the end of Q1 2023 amounted to ¥10,344,014,837.65, an increase of 4.16% from the end of the previous year[31]. - The equity attributable to shareholders at the end of Q1 2023 was ¥8,580,678,446.50, a slight decrease of 0.73% compared to the previous year[31]. - The total current liabilities increased to ¥1,465,819,948.44, up from ¥1,187,825,958.39 in the previous year[22]. - The total liabilities reached ¥1,763,336,391.15, compared to ¥1,287,192,301.61 in the previous year, indicating significant growth in liabilities[22]. - The company's total liabilities and equity as of March 31, 2023, were CNY 10,344,014,837.65, up from CNY 9,931,217,920.38 at the end of 2022[41]. Cash Flow - Cash inflow from operating activities for Q1 2023 was $1,840,680,093.86, a decrease of 17.6% compared to $2,234,135,861.24 in Q1 2022[45]. - Net cash flow from operating activities was $36,012,686.90, down 90.2% from $366,936,776.79 in the same period last year[45]. - Cash inflow from investment activities totaled $1,306,964,370.43, a decline of 54.8% from $2,892,690,531.41 in Q1 2022[46]. - Net cash flow from investment activities was -$195,408,628.00, compared to $425,486,783.03 in Q1 2022[46]. - Cash inflow from financing activities was $382,075,308.95, significantly lower than $1,436,781.77 in Q1 2022[46]. - Net cash flow from financing activities improved to $315,075,308.95 from -$3,863,218.23 in the previous year[46]. - The ending cash and cash equivalents balance for Q1 2023 was $757,913,635.79, down from $1,615,803,328.73 in Q1 2022[46]. - Cash received from the sale of goods and services was $1,835,778,406.55, a decrease from $2,226,235,866.51 in the prior year[45]. - Total cash outflow from operating activities was $1,804,667,406.96, slightly lower than $1,867,199,084.45 in Q1 2022[45]. - Cash paid to employees increased to $93,394,706.15 from $80,584,064.13 in the same quarter last year[45]. Shareholder Information - The company had a total of 12,500,000 ordinary shares held by the largest shareholder, accounting for 2.27% of total shares[9]. - The top three shareholders collectively hold 59,500,000 shares, representing a significant portion of the company's equity[9]. - The total equity attributable to shareholders of the parent company as of March 31, 2023, was CNY 8,580,678,446.50, a slight decrease from CNY 8,644,025,618.77 at the end of 2022[42]. Non-Recurring Items - The company reported a non-recurring loss of ¥203,323.47 from the disposal of non-current assets in Q1 2023[16]. - The total non-recurring profit for the period, after tax effects, was ¥8,561,210.66[16]. Government Support - Government subsidies recognized in the current period amounted to ¥2,741,547.65, which are closely related to the company's normal business operations[16]. Operational Strategy - The company has not reported any significant changes in its operational strategy or market expansion plans for the upcoming quarters[10]. - There were no new product launches or technological advancements mentioned during the earnings call[10]. - The company did not disclose any plans for mergers or acquisitions in the near future[10]. Financial Reporting - The company emphasized its commitment to maintaining accurate and complete financial reporting, ensuring transparency for investors[12]. - The financial data presented in the report has been verified by the company's management, ensuring its reliability[13]. Research and Development - Research and development expenses for Q1 2023 were CNY 6,222,424.39, a decrease of 34.5% from CNY 9,469,402.14 in Q1 2022[41]. - The company reported a financial income of CNY 4,750,343.52 in Q1 2023, compared to a financial expense of CNY 9,433,104.25 in Q1 2022[41]. - The investment income for Q1 2023 was CNY 6,568,712.67, down from CNY 21,286,693.68 in Q1 2022[41].

证券代码：600955 证券简称：维远股份 公告编号：2023-018 利华益维远化学股份有限公司关于召开 2022 年度业绩暨现金分红说明会的公告 重要内容提示： 会议召开时间：2023 年 3 月 16 日(星期四)下午 15:00-16:30 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心视频和网络互动 投资者可于 2023 年 3 月 9 日(星期四)至 3 月 15 日(星期三)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮 箱 wyhxzqb@163.com 进行提问。公司将在说明会上对投资者普遍关注 的问题进行回答。 利华益维远化学股份有限公司（以下简称"公司"）已于 2023 年 3 月 2 日发布公司 2022 年度报告，为便于广大投资者更全面深入 地了解公司 2022 年度经营成果、财务状况，公司计划于 2023 年 3 月 16 日下午 15:00-16:30 举行 2022 年度业绩暨现金分红说明会，就投 资者关心的问题进行交流。 本公司董事会及全体董事保证本公告内容不存 ...

Financial Performance - The company's total revenue for 2022 was ¥7,798,113,240.28, a decrease of 19.06% compared to ¥9,634,615,988.64 in 2021[15]. - The net profit attributable to shareholders was ¥607,773,517.58, down 71.73% from ¥2,149,712,903.46 in the previous year[15]. - The net cash flow from operating activities was ¥1,083,840,671.44, a decline of 59.49% compared to ¥2,675,353,773.66 in 2021[15]. - The company's operating revenue decreased by 19.06% compared to the same period last year, primarily due to a decline in sales prices of certain products and periodic maintenance of some facilities[30]. - The gross profit margin for the phenol business decreased by 15.71 percentage points, with revenue down by 11.61% and costs up by 7.86%[31]. - The gross profit margin for new materials decreased by 34.44 percentage points, with revenue down by 35.87% and costs down by 1.18%[31]. - The company's revenue for the current period is approximately ¥7.80 billion, a decrease of 19.06% compared to ¥9.63 billion in the same period last year[56]. - The company reported a significant decrease in net cash flow from financing activities, down 109.29% to -¥241.90 million from ¥2.60 billion in the previous year[56]. - The company reported a total of 988 employees, with 799 in production, 13 in sales, 47 in technology, 10 in finance, and 119 in administration[170]. Cost and Expenses - Operating costs increased by 5.21% year-on-year, mainly due to the rise in prices of key raw materials[30]. - Research and development expenses rose by 81.39% compared to the previous year, attributed to increased R&D projects and investments[30]. - The cash paid for purchasing goods and services was CNY 7.30 billion, an increase from CNY 6.49 billion in the previous year[96]. - The cost of direct materials for phenol-related products was ¥4,119,703,972.37, accounting for 58.95% of total costs, reflecting a 9.21% increase from the previous year[3]. - The cost of phenol increased by 19.57% year-on-year, amounting to CNY 2.10 billion, which accounted for 30.00% of total costs[89]. - The cost of acetone decreased by 29.11% year-on-year, totaling CNY 601 million, which represented 8.60% of total costs[89]. - The cost of bisphenol A increased by 8.21% year-on-year, reaching CNY 883 million, accounting for 12.64% of total costs[89]. Inventory and Assets - The company reported a significant increase in inventory levels, with a 32.46% rise in one category, indicating potential overproduction or decreased sales[2]. - The total assets at the end of 2022 were ¥9,931,217,920.38, an increase of 7.57% from ¥9,232,365,978.00 in 2021[15]. - The total amount of financial assets at the end of the period was approximately 1.653 billion RMB, after accounting for significant purchases and sales during the year[79]. - As of the end of the reporting period, cash and cash equivalents amounted to ¥1,015,522,517.85, accounting for 10.23% of total assets, a decrease of 1.48% from the previous period[117]. - The company's trading financial assets decreased by 55.74% to ¥1,652,784,111.74, representing 16.64% of total assets, due to the reduction in idle funds used for financial products[117]. - Inventory increased by 20.43% to ¥372,328,436.64, accounting for 3.75% of total assets[117]. - The company has increased its construction in progress significantly by 750.55% to ¥2,043,589,679.78, which now represents 20.58% of total assets[117]. Strategic Initiatives - The company has developed four general-purpose and two flame-retardant grade PC/ABS alloy new products, achieving industrial transformation and targeting high-end market applications[28]. - The company aims to enhance its production chain by building new facilities for high-purity dimethyl carbonate and propane dehydrogenation, contributing to the new energy industry chain[20]. - The company is actively developing a propane dehydrogenation-epoxy propane-electrolyte solvent industrial chain, along with products like food-grade carbon dioxide and high-performance polypropylene[53]. - The company plans to continue expanding its production capacity to meet the growing demand in downstream applications such as coatings and electronics[53]. - The company is focusing on risk management and production safety while ensuring the stable operation of production facilities and the smooth construction of new projects[20]. - The company aims to explore favorable opportunities for importing propylene and pure benzene to reduce operational costs[111]. - The company has established long-term partnerships with stable raw material suppliers to mitigate risks associated with price fluctuations[97]. - The company is committed to developing advanced green production processes to enhance its competitive advantage in the market[82]. Research and Development - The total number of R&D personnel is 51, representing 5.16% of the total workforce[142]. - The company is focusing on enhancing R&D investment and innovation capabilities in line with national policies for the chemical industry[154]. - The company has no capitalized R&D expenditures for the current period[141]. - The company has implemented a training program for employees, focusing on operational procedures, safety regulations, and quality control[188]. - The company has collaborated with universities and advanced enterprises for employee training, enhancing the quality and efficiency of talent development[188]. Environmental and Social Responsibility - The company invested ¥21,319.14 million in environmental protection during the reporting period[196]. - The company is committed to reducing carbon emissions and promoting sustainable development in its future operations[187]. - The company has invested in pollution prevention facilities, significantly reducing volatile organic compound emissions[199]. - The company's pollution control facilities operated normally, with stable compliance in pollutant emissions[181]. - The company's environmental protection measures are in compliance with standards, with no exceedances reported in pollutant emissions[180]. Shareholder Information - The company distributed cash dividends of 91,300,000.00 yuan, with a cash dividend ratio of 15.02% based on a total share capital of 550,000,000 shares[36]. - The cash dividend policy for 2022 is set at 1.66 RMB per 10 shares, totaling 91,300,000 RMB distributed to shareholders[173]. - The cash dividend for the year was ¥91,300,000.00, representing 15.02% of the net profit attributable to ordinary shareholders in the consolidated financial statements[192]. - The company has a total share capital of 550,000,000 shares as of December 31, 2022[173].

证券代码：600955 证券简称：维远股份 公告编号：2022-060 利华益维远化学股份有限公司 关于参加山东辖区上市公司2022年度投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证本公告内容不存在虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 为进一步加强与广大投资者的沟通交流，做好投资者关系管理工作， 利华益维远化学股份有限公司（以下简称"公司"）将参加由山东证监局、 山东上市公司协会联合举办的"山东辖区上市公司 2022 年度投资者网上集 体接待日"活动，现将有关事项公告如下： 本次活动将通过深圳市全景网络有限公司提供的互联网平台举行，投 资者可以登录全景网"投资者关系互动平台"（http://ir.p5w.net/）参与本 次活动，活动时间为：2022 年 11 月 16 日（星期三）14:00 至 16:00。 届时公司董事长魏玉东先生，董事、总经理李秀民先生，董事、副总经 理、董事会秘书吕立强先生，董事、副总经理、财务总监宋成国先生将通 过网络在线互动的形式，与投资者进行沟通和交流。欢迎广大投资者积极 参与。 特此公告。 利华益维远化学股份 ...

Financial Performance - The company's operating revenue for Q3 2022 was ¥1,924,821,003.89, a decrease of 25.46% compared to the same period last year[7]. - The net profit attributable to shareholders for Q3 2022 was ¥32,253,813.79, down 94.49% year-on-year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥20,423,644.38, a decline of 96.51% compared to the previous year[7]. - The basic earnings per share for Q3 2022 was ¥0.06, a decrease of 95.41% year-on-year[9]. - The diluted earnings per share for Q3 2022 was also ¥0.06, reflecting a 95.41% decline compared to the same period last year[9]. - Total operating revenue for the first three quarters of 2022 was CNY 5,894,173,705.35, a decrease of 19.8% compared to CNY 7,348,279,699.86 in the same period of 2021[30]. - Net profit attributable to shareholders of the parent company was CNY 491,116,079.73, a significant decline of 73.0% from CNY 1,822,851,216.81 in the previous year[34]. - The total comprehensive income attributable to shareholders of the parent company was CNY 491,116,079.73, down from CNY 1,822,851,216.81, reflecting a decrease of 73.0%[36]. Assets and Liabilities - The total assets at the end of Q3 2022 were ¥9,422,149,627.58, an increase of 2.06% from the end of the previous year[9]. - The equity attributable to shareholders at the end of Q3 2022 was ¥8,528,386,472.77, up 3.39% from the end of the previous year[9]. - The total liabilities decreased to CNY 893,763,154.81 from CNY 983,580,869.56, reflecting a reduction of approximately 9.1%[28]. - The total equity attributable to shareholders of the parent company increased to CNY 8,528,386,472.77, up from CNY 8,248,785,108.44, representing a growth of 3.4%[28]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥757,745,789.33, down 68.53% year-on-year[9]. - The net cash flow from operating activities for the first three quarters of 2022 was ¥757,745,789.33, a decrease of 68.5% compared to ¥2,407,871,810.28 in the same period of 2021[41]. - Total cash inflow from operating activities was ¥6,788,949,575.41, down from ¥8,434,497,007.47 in the previous year, reflecting a decline of 19.5%[41]. - Cash outflow for purchasing goods and services increased to ¥5,495,869,056.15, compared to ¥4,951,550,982.48 in 2021, marking an increase of 11%[41]. - Cash inflow from investment activities reached ¥6,733,296,202.42, significantly higher than ¥1,666,198,314.26 in the previous year, indicating a growth of 303.5%[41]. - The net cash flow from investment activities was -¥435,507,107.82, an improvement from -¥592,658,252.73 in the same period last year[41]. - Cash inflow from financing activities totaled ¥108,907,800.80, a sharp decline from ¥4,256,264,960.24 in 2021[41]. - The net cash flow from financing activities was -¥227,249,865.85, compared to a positive cash flow of ¥2,654,562,711.56 in the previous year[41]. - The ending balance of cash and cash equivalents was ¥922,231,808.99, a significant decrease from ¥4,659,637,476.45 at the end of the previous year[41]. Inventory and Expenses - The company's current assets decreased to CNY 3,609,824,710.61 from CNY 5,118,845,196.41 year-over-year[23]. - The company's inventory increased to CNY 367,532,824.65 from CNY 309,177,068.35 year-over-year, indicating a growth of approximately 18.9%[23]. - The total non-current assets rose to CNY 5,812,324,916.97 from CNY 4,113,520,781.59, reflecting a significant increase of about 41.3%[23]. - Total operating costs increased to CNY 5,317,112,699.25, up 7.9% from CNY 4,920,416,508.48 year-over-year[30]. - Research and development expenses rose significantly to CNY 21,893,677.87, compared to CNY 5,942,403.03 in the previous year, indicating an increase of 268.5%[30]. Shareholder Information - The company has a total of 108,500,000 shares held by the largest shareholder, accounting for 19.73% of the total shares[16]. - The company has no significant changes in the status of pledged, marked, or frozen shares among its major shareholders[16]. Financial Performance Changes - The decline in profits is primarily attributed to falling product prices and rising raw material costs[11]. - The company reported a financial income of CNY 28,357,185.03, compared to a financial expense of CNY 26,230,576.51 in the previous year, showing a turnaround in financial performance[30]. - Deferred income increased to CNY 91,183,881.55 from CNY 82,890,596.50, marking an increase of 9.7%[28].

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 3,969,352,701.46, a decrease of 16.71% compared to CNY 4,765,942,106.45 in the same period last year [23]. - The net profit attributable to shareholders of the listed company was CNY 458,862,265.94, down 62.91% from CNY 1,237,321,324.36 year-on-year [23]. - The net cash flow from operating activities was CNY 523,196,444.69, a decline of 67.01% compared to CNY 1,585,951,105.41 in the previous year [23]. - The basic earnings per share for the first half of 2022 was CNY 0.83, a decrease of 72.33% from CNY 3.00 in the same period last year [26]. - The weighted average return on net assets was 5.48%, down 38.16 percentage points from 43.64% year-on-year [26]. - The net profit after deducting non-recurring gains and losses was CNY 424,710,872.88, a decrease of 65.59% compared to CNY 1,234,098,206.23 in the same period last year [23]. - The diluted earnings per share also stood at CNY 0.83, reflecting the same decline of 72.33% from CNY 3.00 year-on-year [26]. - The company achieved a sales revenue of CNY 396,935,270.46, a decrease of 16.71% compared to the same period last year [46]. - The net profit attributable to shareholders was CNY 45,886,230.00, reflecting the impact of rising raw material prices and periodic equipment maintenance [45]. - Operating cash flow decreased by 67.01% to CNY 523,196,444.69, primarily due to increased raw material costs and reduced sales volume [46]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 9,535,887,687.50, an increase of 3.29% from CNY 9,232,365,978.00 at the end of the previous year [23]. - The net assets attributable to shareholders of the listed company increased by 2.97% to CNY 8,493,595,535.57 from CNY 8,248,785,108.44 at the end of the previous year [23]. - Inventory rose by 41.54% to CNY 437,608,943.28, attributed to increased quantities and costs of raw materials and finished goods [53]. - The total liabilities increased to ¥1,042,292,151.93 from ¥983,580,869.56, reflecting a rise of about 5.9% [121]. - Current liabilities totaled ¥955,331,544.44, compared to ¥900,690,273.06, reflecting an increase of about 6.0% [121]. - Non-current assets amounted to ¥4,840,135,724.68, up from ¥4,113,520,781.59, indicating a growth of approximately 17.7% [121]. Research and Development - The company has established a robust technology innovation mechanism, including a reward system for innovation and increased investment in research and development [37]. - Research and development expenses surged by 654.88% to CNY 15,484,516.31, indicating a significant increase in R&D projects and investments [46]. - Research and development expenses rose significantly to CNY 15,484,516.31, compared to CNY 2,051,256.60 in the first half of 2021, marking a 653.09% increase [130]. Market and Industry Outlook - The phenol market in China is expected to see increased demand in the second half of 2022, driven by a tight supply-demand balance and rising prices due to strong international crude oil prices [32]. - The acetone downstream demand structure is changing, with the methyl methacrylate/acetone cyanohydrin sector projected to account for over 25% of acetone demand in 2022 [33]. Environmental and Compliance - The company has committed to environmental protection measures, including the establishment of an environmental protection department to oversee compliance and pollution control [83]. - The company has established an environmental monitoring system that operates continuously and is connected to regulatory authorities for real-time oversight [80]. - The company has implemented a strict "three simultaneous" system for pollution control facilities, ensuring they are designed, constructed, and put into operation concurrently with production facilities [77]. - The company has not faced any administrative penalties for environmental issues during the reporting period [81]. - The company invested in a comprehensive treatment project for volatile organic compounds, further reducing emissions beyond compliance levels [77]. Shareholder and Corporate Governance - The company committed to not engage in any competitive business activities directly or indirectly for 36 months from the listing date, September 15, 2021 [90]. - The lock-up period for major shareholders is set for 36 months post-listing, with specific conditions for extending this period if stock prices fall below the issue price [90]. - Major shareholders are restricted from transferring shares for 12 months post-listing, with a maximum annual reduction of 25% thereafter [90]. - The company has maintained compliance with all legal and regulatory requirements regarding related party transactions [90]. - There were no significant lawsuits or arbitration matters during the reporting period [96]. Financial Instruments and Accounting - The company recognizes interest income based on the effective interest method, with specific treatments for credit-impaired financial assets [192]. - Financial assets are classified based on the business model and cash flow characteristics, with specific criteria for measuring at amortized cost or fair value [191]. - The company recognizes financial liabilities at fair value through profit or loss, including trading financial liabilities and those designated at fair value upon initial recognition [198]. - Financial assets and liabilities are presented separately in the balance sheet and are not offset unless specific conditions are met [199].